ArticleRSC advances2025
Reverse micelle-mediated synthesis of precision-controlled FeS nanospheres and their role in tailored FeS@PANI nanocomposites.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we introduce a novel approach that combines reverse micelle-mediated synthesis of FeS nanospheres with Pickering emulsion-templated polymerization, offering the unveiling of an unexplored strategy for precise control over the size and morphology of FeS@PANI nanocomposites. Unlike prior studies, which did not focus the role of Pickering emulsions in directing polymer growth, this present approach leverages emulsion interface stabilization and micellar confinement to regulate polymerization dynamics and composite architecture. Using reverse micelles composed of SPAN 80, 1-butanol, toluene, and FeS, five distinct water-to-surfactant (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.